Jim Simons Atara Biotherapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 980,385 shares of ATRA stock, worth $7.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

980,385

Previous 622,911 57.39%

Holding current value

$7.56 Million

Previous $319,000 113.17%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.44 - $1.22 $157,288 - $436,118	357,474 Added 57.39%	980,385 $680,000
Q4 2023 Feb 13, 2024	SELL	$0.23 - $1.74 $47,426 - $358,788	-206,200 Reduced 24.87%	622,911 $319,000
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $1.82 Million - $2.97 Million	-1,287,789 Reduced 60.83%	829,111 $1.23 Million
Q2 2023 Aug 11, 2023	BUY	$1.5 - $3.04 $1.02 Million - $2.06 Million	679,200 Added 47.24%	2,116,900 $3.41 Million
Q1 2023 May 12, 2023	BUY	$2.8 - $5.46 $3.56 Million - $6.95 Million	1,272,700 Added 771.33%	1,437,700 $4.17 Million

Q4 2022 Feb 13, 2023	SELL	$2.85 - $5.18 $487,635 - $886,298	-171,100 Reduced 50.91%	165,000 $541,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $316,065 - $968,157	110,900 Added 49.25%	336,100 $1.27 Million
Q2 2022 Aug 12, 2022	SELL	$4.69 - $9.84 $1.62 Million - $3.39 Million	-344,600 Reduced 60.48%	225,200 $1.75 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $16.89 $4.81 Million - $9.62 Million	569,800 New	569,800 $5.29 Million
Q4 2021 Feb 11, 2022	SELL	$14.7 - $19.89 $4.14 Million - $5.6 Million	-281,679 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $7.4 Million - $11 Million	-617,021 Reduced 68.66%	281,679 $5.04 Million
Q2 2021 Aug 13, 2021	BUY	$12.89 - $16.58 $4.8 Million - $6.18 Million	372,600 Added 70.82%	898,700 $14 Million
Q1 2021 May 13, 2021	BUY	$14.0 - $20.72 $7.08 Million - $10.5 Million	505,500 Added 2453.88%	526,100 $7.56 Million
Q4 2020 Feb 10, 2021	BUY	$12.67 - $26.23 $261,002 - $540,338	20,600 New	20,600 $404,000
Q2 2020 Aug 13, 2020	SELL	$7.53 - $14.93 $192,768 - $382,208	-25,600 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$5.69 - $17.78 $145,664 - $455,168	25,600 New	25,600 $218,000
Q3 2019 Nov 13, 2019	SELL	$12.03 - $19.94 $1.83 Million - $3.03 Million	-152,148 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$19.05 - $41.04 $2.9 Million - $6.24 Million	152,148 New	152,148 $3.06 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account